Jointechlabs develops regenerative medicine therapies such as MiniTC® & Mini-Stem System® - devices to process body fat in non-surgical use.
Jointechlabs is an emerging world leader in point-of-care regenerative medicine therapies with its headquarters in Chicago, IL. Current products include MiniTC® (for USA) and Mini-Stem System® (for Ex-USA) - medical devices that allow processing of autologous (your own) body fat for use in non-surgical orthopedic and aesthetic procedures in your doctor’s office, providing safe, time efficient, and superior results. Pipeline products include biologic drugs and 3D Bioprinted products to further expand use in orthopedic, wound healing and plastic and reconstructive surgery . For more information, please visit: https://jointechlabs.com/.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jun 8, 2021 | Seed | $200K | 1 | — | — | Detail |
Apr 1, 2021 | Pre-seed | $25K | 2 | — | — | Detail |
Apr 18, 2018 | Seed | $1.50M | 2 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
EXPERT DOJO | — | Seed |
Stemtech LLC | — | Pre-seed |